Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × trastuzumab deruxtecan × Clear all

Phase

Status

Recruiting 59 Active not recruiting 22 Completed 18 Not yet recruiting 13 Terminated 5 Unknown 2 Suspended 2 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 100 Radiotherapy 99 Cisplatin 97 pembrolizumab 92 Paclitaxel 74 Carboplatin 73 Nivolumab 67 Gemcitabine 67 Magnetic Resonance Spectroscopy 64 Fluorouracil 63 Dexamethasone 57 Bevacizumab 56 Radiosurgery 53 Docetaxel 51 Rituximab 48 Oxaliplatin 47 Leucovorin 47 fludarabine 45 Capecitabine 44 Biopsy 44 Doxorubicin 37 Drug Therapy 36 durvalumab 35 Etoposide 34 Cytarabine 34 fludarabine phosphate 33 Radiation 33 Pemetrexed 32 Lenalidomide 32 Specimen Handling 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06585969 2026-02-12

DISCORDANT

Danish Breast Cancer Cooperative Group

Phase 3 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡